International Assets Investment Management LLC decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 6.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,280 shares of the company’s stock after selling 235 shares during the quarter. International Assets Investment Management LLC’s holdings in Zoetis were worth $511,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in the business. Swmg LLC boosted its holdings in Zoetis by 19.3% during the second quarter. Swmg LLC now owns 1,884 shares of the company’s stock worth $284,000 after purchasing an additional 305 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Zoetis during the second quarter worth $11,104,000. Novare Capital Management LLC raised its position in Zoetis by 0.5% during the second quarter. Novare Capital Management LLC now owns 96,171 shares of the company’s stock worth $14,998,000 after acquiring an additional 501 shares in the last quarter. Quotient Wealth Partners LLC raised its position in Zoetis by 38.6% during the second quarter. Quotient Wealth Partners LLC now owns 4,391 shares of the company’s stock worth $685,000 after acquiring an additional 1,224 shares in the last quarter. Finally, Stanley Laman Group Ltd. raised its position in Zoetis by 11.3% during the second quarter. Stanley Laman Group Ltd. now owns 1,977 shares of the company’s stock worth $308,000 after acquiring an additional 200 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on ZTS. Argus reaffirmed a “buy” rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. UBS Group dropped their price target on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research report on Monday. Finally, Piper Sandler upped their price target on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $195.00.
Zoetis Price Performance
Shares of ZTS opened at $146.13 on Wednesday. The firm has a market capitalization of $64.76 billion, a PE ratio of 25.15, a PEG ratio of 2.33 and a beta of 0.90. The company’s 50-day moving average is $148.58 and its 200-day moving average is $153.55. Zoetis Inc. has a fifty-two week low of $139.34 and a fifty-two week high of $189.98. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04.
Zoetis (NYSE:ZTS – Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company’s revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.
Zoetis Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. Zoetis’s dividend payout ratio is presently 34.42%.
Zoetis Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
- Five stocks we like better than Zoetis
- Dividend Capture Strategy: What You Need to Know
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- The How And Why of Investing in Oil Stocks
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What is Short Interest? How to Use It
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.